Silencing of LRRFIP1 reverses the epithelial-mesenchymal transition via inhibition of the Wnt/β-catenin signaling pathway

Cancer Letters

Volumn 365, Issue 1, 2015, Pages 132-140

  Douchi, Daisuke ^a   Ohtsuka, Hideo ^a   Ariake, Kyohei ^a   Masuda, Kunihiro ^a   Kawasaki, Shuhei ^a   Kawaguchi, Kei ^a   Fukase, Koji ^a   Oikawa, Masaya ^a   Motoi, Fuyuhiko ^a   Naitoh, Takeshi ^a   Katayose, Yu ^a   Egawa, Shinichi ^a   Unno, Michiaki ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

EMT; LRRFIP1; Reverse EMT; Wnt catenin signaling; catenin destruction complex

Indexed keywords

BETA CATENIN; SMALL INTERFERING RNA; UVOMORULIN; VIMENTIN; WNT PROTEIN; CADHERIN; CDH1 PROTEIN, HUMAN; CTNNB1 PROTEIN, HUMAN; LRRFIP1 PROTEIN, HUMAN; RNA BINDING PROTEIN;

ARTICLE; CANCER INHIBITION; CELL INVASION; CELL MEMBRANE; CELL MIGRATION; CELL NUCLEUS; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG TARGETING; EPITHELIAL MESENCHYMAL TRANSITION; GENE; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; LRRFIP1 GENE; LUNG CANCER; LUNG CANCER CELL LINE; PANCREAS CANCER; PANCREATIC CANCER CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; UPREGULATION; ACTIVE TRANSPORT; CELL MOTION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; LUNG TUMOR; METABOLISM; PANCREAS TUMOR; PATHOLOGY; PHOSPHORYLATION; PROMOTER REGION; TUMOR CELL LINE; TUMOR INVASION; WNT SIGNALING PATHWAY;

ACTIVE TRANSPORT, CELL NUCLEUS; BETA CATENIN; CADHERINS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; NEOPLASM INVASIVENESS; PANCREATIC NEOPLASMS; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; RNA INTERFERENCE; RNA-BINDING PROTEINS; TRANSFECTION; WNT SIGNALING PATHWAY;

EID: 84930822999     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2015.05.023     Document Type: Article

References (45)

1. Steeg P.S. Tumor metastasis: mechanistic insights and clinical challenges. Nat. Med 2006, 12:895-904.
2. Valastyan S., Weinberg R.A. Tumor metastasis: molecular insights and evolving paradigms. Cell 2011, 147:275-292.
3. Gupta G.P., Massague J. Cancer metastasis: building a framework. Cell 2006, 127:679-695.
4. Fidler I.J. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat. Rev. Cancer 2003, 3:453-458.
5. Thiery J.P., Acloque H., Huang R.Y., Nieto M.A. Epithelial-mesenchymal transitions in development and disease. Cell 2009, 139:871-890.
6. Klymkowsky M.W., Savagner P. Epithelial-mesenchymal transition: a cancer researcher's conceptual friend and foe. Am. J. Pathol 2009, 174:1588-1593.
7. Min C., Eddy S.F., Sherr D.H., Sonenshein G.E. NF-κB and epithelial to mesenchymal transition of cancer. J. Cell. Biochem 2008, 104:733-744.
8. Polyak K., Weinberg R.A. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat. Rev. Cancer 2009, 9:265-273.
9. Barrallo-Gimeno A., Nieto M.A. The Snail genes as inducers of cell movement and survival: implications in development and cancer. Development 2005, 132:3151-3161.
10. Stewart C.J.R., McCluggage W.G. Epithelial-mesenchymal transition in carcinomas of the female genital tract. Histopathology 2013, 62:31-43.
11. MacDonald B.T., Tamai K., He X. Wnt/β-catenin signaling: components, mechanisms, and diseases. Dev. Cell 2009, 17:9-26.
12. Zhang Y., Morris J.P., Yan W., Schofield H.K., Gurney A., Simeone D.M., et al. Canonical Wnt signaling is required for pancreatic carcinogenesis. Cancer Res 2013, 73:4909-4922.
13. Morris J.P., Wang S.C., Hebrok M. KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma. Nat. Rev. Cancer 2010, 10:683-695.
14. Angers S., Moon R.T. Proximal events in Wnt signal transduction. Nat. Rev. Mol. Cell Biol 2009, 10:468-477.
15. Sugimura R., Li L. Noncanonical Wnt signaling in vertebrate development, stem cells, and diseases. Birth Defects Res. C Embryo Today 2010, 90:243-256.
16. Stamos J.L., Weis W.I. The β-catenin destruction complex. Cold Spring Harb. Perspect. Biol 2013, 5:a007898.
17. Schmalhofer O., Brabletz S., Brabletz T. E-cadherin, β-catenin, and ZEB1 in malignant progression of cancer. Cancer Metastasis Rev 2009, 28:151-166.
18. Gavert N., Ben-Ze'ev A. β-Catenin signaling in biological control and cancer. J. Cell. Biochem 2007, 102:820-828.
19. Heuberger J., Birchmeier W. Interplay of cadherin-mediated cell adhesion and canonical Wnt signaling. Cold Spring Harb. Perspect. Biol 2010, 2:a002915.
20. Onder T.T., Gupta P.B., Mani S.A., Yang J., Lander E.S., Weinberg R.A. Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res 2008, 68:3645-3654.
21. Fagotto F., Funayama N., Gliick U., Gumbiner B.M. Binding to cadherins antagonizes the signaling activity of β-catenin during axis formation in Xenopus. J. Cell Biol 1996, 132:1105-1114.
22. Heasman J., Crawford A., Goldstone K., Garner-Hamrick P., Gumbiner B., McCrea P., et al. Overexpression of cadherins and underexpression of β-catenin inhibit dorsal mesoderm induction in early Xenopus embryos. Cell 1994, 79:791-803.
23. Kim W., Kim M., Jho E.H. Wnt/β-catenin signalling: from plasma membrane to nucleus. Biochem. J. 2013, 450:9-21.
24. Valenta T., Hausmann G., Basler K. The many faces and functions of β-catenin. EMBO J. 2012, 31:2714-2736.
25. Reed A.L., Yamazaki H., Kaufman J.D., Rubinstein Y., Murphy B., Johnson A.C. Molecular cloning and characterization of a transcription regulator with homology to GC-binding factor. J. Biol. Chem 1998, 273:21594-21602.
26. Ohtsuka H., Oikawa M., Ariake K., Rikiyama T., Motoi F., Katayose Y., et al. GC-binding factor 2 interacts with dishevelled and regulates Wnt signaling pathways in human carcinoma cell lines. Int. J. Cancer 2011, 129:1599-1610.
27. Dai P., Jeong S.Y., Yu Y., Leng T., Wu W., Xie L., et al. Modulation of TLR signaling by multiple MyD88-interacting partners including leucine-rich repeat Fli-I-interacting proteins. J. Immunol 2009, 182:3450-3460.
28. Ariake K., Ohtsuka H., Motoi F., Douchi D., Oikawa M., Rikiyama T., et al. GCF2/LRRFIP1 promotes colorectal cancer metastasis and liver invasion through integrin-dependent RhoA activation. Cancer Lett 2012, 325:99-107.
29. Bo H., Zhang S., Gao L., Chen Y., Zhang J., Chang X., et al. Upregulation of Wnt5a promotes epithelial-to-mesenchymal transition and metastasis of pancreatic cancer cells. BMC Cancer 2013, 13:496.
30. Schneider C.A., Rasband W.S., Eliceiri K.W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 2012, 9:671-675.
31. Schmidt-Ott K.M., Barasch J. WNT/beta-catenin signaling in nephron progenitors and their epithelial progeny. Kidney Int 2008, 74:1004-1008.
32. von Wasielewski R., Rhein A., Werner M., Scheumann G.F., Dralle H., Pötter E., et al. Immunohistochemical detection of E-cadherin in differentiated thyroid carcinomas correlates with clinical outcome. Cancer Res 1997, 57:2501-2507.
33. Richmond P.J.M., Karayiannakis A.J., Nagafuchi A., Kaisary A.V., Pignatelli M. Aberrant E-cadherin and α-catenin expression in prostate cancer: correlation with patient survival. Cancer Res 1997, 57:3189-3193.
34. Sjoblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D., et al. The consensus coding sequences of human breast and colorectal cancers. Science 2006, 314:268-274.
35. Thiery J.P. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2002, 2:442-454.
36. Thompson E.W., Newgreen D.F., Tarin D. Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition?. Cancer Res 2005, 65:5991-5995.
37. Thiery J.P., Sleeman J.P. Complex networks orchestrate epithelial-mesenchymal transitions. Nat. Rev. Mol. Cell Biol 2006, 7:131-142.
38. Jamora C., DasGupta R., Kocieniewski P., Fuchs E. Links between signal transduction, transcription and adhesion in epithelial bud development. Nature 2003, 422:317-322.
39. Vallin J., Thuret R., Giacomello E., Faraldo M.M., Thiery J.P., Broders F. Cloning and characterization of three Xenopus slug promoters reveal direct regulation by Lef/β-catenin signaling. J. Biol. Chem 2001, 276:30350-30358.
40. Howe L.R., Watanabe O., Leonard J. Twist is up-regulated in response to Wnt1 and inhibits mouse mammary cell differentiation. Cancer Res 2003, 63:1906-1913.
41. Sánchez-Tilló E., de Barrios O., Siles L., Cuatrecasas M., Castellse A., Postigo A. β-Catenin/TCF4 complex induces the epithelial-to-mesenchymal transition (EMT)-activator ZEB1 to regulate tumor invasiveness. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:19204-19209.
42. Zhou B.P., Deng J., Xia W., Xu J., Li Y.M., Gunduz M., et al. Dual regulation of snail by GSK-3β-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat. Cell Biol 2004, 6:931-940.
43. Bachelder R.E., Yoon S.O., Franci C., de Herreros A.G., Mercurio A.M. Glycogen synthase kinase-3 is an endogenous inhibitor of Snail transcription: implications for the epithelial-mesenchymal transition. J. Cell Biol 2005, 168:29-33.
44. Wu Z.-Q., Brabletzb T., Fearon E., Willis A.L., Hu C.Y., Li X.-Y., et al. Canonical Wnt suppressor, Axin2, promotes colon carcinoma oncogenic activity. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:11312-11317.
45. Mariadason J.M., Bordonaro M., Aslam F., Shi L., Kuraguchi M., Velcich A., et al. Down-regulation of β-catenin TCF signaling is linked to colonic epithelial cell differentiation. Cancer Res 2001, 61:3465-3471.